Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

AVITA Medical (RCEL) Receivables - Other (2020 - 2024)

AVITA Medical's Receivables - Other history spans 5 years, with the latest figure at $94000.0 for Q2 2024.

  • For Q2 2024, Receivables - Other fell 78.73% year-over-year to $94000.0; the TTM value through Jun 2024 reached $94000.0, down 78.73%, while the annual FY2024 figure was $56000.0, 86.67% up from the prior year.
  • Receivables - Other reached $94000.0 in Q2 2024 per RCEL's latest filing, up from $28000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $3.9 million in Q2 2021 to a low of $28000.0 in Q1 2024.
  • Average Receivables - Other over 5 years is $826533.3, with a median of $442000.0 recorded in 2023.
  • Peak YoY movement for Receivables - Other: skyrocketed 1005.62% in 2021, then tumbled 96.66% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $125000.0 in 2020, then soared by 146.4% to $308000.0 in 2021, then surged by 191.56% to $898000.0 in 2022, then crashed by 96.66% to $30000.0 in 2023, then soared by 213.33% to $94000.0 in 2024.
  • Per Business Quant, the three most recent readings for RCEL's Receivables - Other are $94000.0 (Q2 2024), $28000.0 (Q1 2024), and $30000.0 (Q4 2023).